Uploaded image for project: 'eCQM Issue Tracker'
  1. eCQM Issue Tracker
  2. CQM-1391

VTE Prophylaxis for VTE 3 related to Total Knee and Total Hip Replacements

XMLWordPrintable

    • Icon: EH/CAH eCQMs - Eligible Hospitals/Critical Access Hospitals EH/CAH eCQMs - Eligible Hospitals/Critical Access Hospitals
    • Resolution: Answered
    • Icon: Minor Minor
    • ValueSet
    • None
    • Pat Standifer
    • 865-647-2901
    • Tennova Healthcare
    • Question/Addition of Additional Medications
    • Hide
      Thank you for your question. Regarding oral factor Xa inhibitors, CMS73v3 (VTE-3) numerator criteria explicitly allow for patients being administered oral factor Xa inhibitors, which would include patients undergoing hip or knee replacement surgery, as well as patients with atrial fibrillation and patients being treated for VTE with oral factor Xa inhibitors. Aspirin is not included in the numerator criteria because while it can be used for VTE *prophylaxis* for hip and knee replacement patients, it isn’t appropriate for VTE *treatment*, which is the focus of this measure.
      Show
      Thank you for your question. Regarding oral factor Xa inhibitors, CMS73v3 (VTE-3) numerator criteria explicitly allow for patients being administered oral factor Xa inhibitors, which would include patients undergoing hip or knee replacement surgery, as well as patients with atrial fibrillation and patients being treated for VTE with oral factor Xa inhibitors. Aspirin is not included in the numerator criteria because while it can be used for VTE *prophylaxis* for hip and knee replacement patients, it isn’t appropriate for VTE *treatment*, which is the focus of this measure.
    • CMS73v3/NQF0373
    • Risk to Orders for VTE Prophylaxis

      According to CMS VTE Manual Revisions for January, 2014, it appears that aspirin and rivaroxaban are acceptable medications for total hip and total knee replacements. These two drugs are not included in the algorithm for reason for exclusion for no parenteral anticoagulant therapy.

            JLeflore Joelencia Leflore
            prsrn326 Patricia Standifer (Inactive)
            Patricia Standifer (Inactive)
            Votes:
            0 Vote for this issue
            Watchers:
            2 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: